Abstract
Introduction

37
In 2016, there were approximately 2.14 million reported cases of Hand, Foot and BrCr strain (S1-3') prototype strain carrying mutations in the 3'-NTR, 3D
pol and 5'-NTR 54 was constructed by Arita et al. (2007) . Although there was reduced virulence, mild 55 neurological symptoms were still observed in the 3 cynomolgus monkeys immunized with 56 the EV-A71 (S1-3') strain. Hence, the plan to use this strain as a LAV was discontinued 57 (Arita et al., 2007) .
58
Before an effective LAV can be developed, there is a need to identify the genetic (VP1-145G) (Kataoka et al., 2015) .
74
The analysis of significant molecular determinants of virulence that were responsible 75 for the attenuated phenotypes of the Sabin Oral Polio Vaccine (OPV) strains was due to the 76 complete sequences of 3 poliovirus (PV) genomes and the development of infectious PV 77 cDNA clones. For example, the Sabin 1 strain differed from its wild type strain with 57 nt.
78
substitutions (Nomoto et al., 1982) . It was found that the A480G in the IRES region is the 79 most vital determinant of virulence that contributed to the attenuation in the Sabin 1 strain.
80
It could be possible that nt. 480 affects the formation of a structure in the 5'-NTR 81 responsible for neuro-virulence (Kawamura et al., 1989 
In vitro transcription of SP6 promoter
217
RNA transcription was performed utilizing the RiboMAX™ Large Scale RNA Production 
Statistical Analysis
283
Based on the data of at least three independent biological replicates, the mean ± standard 284 deviation was calculated. Statistical significance was determined with the Mann-Whitney 285 test, whereby a p value of < 0.05 was considered as statistically significant. 
Results
287
Cytopathic effects (CPE) caused by EV-A71 mutants
288
The EV-A71 sub-genotype B4 virus (5865/Sin/000009) was genetically engineered to shows that there remains some degree of attenuation.
347
In addition, the mutant VP1-E145G displayed significant decreases in viral RNA copy expressed by mutants VP1-98E and G64R (3D pol ) at 7.8 X 10 2 and 1.4 X 10 3 , respectively. 
364
were consistent with the cytopathic effect, TCID50 infectivity and viral RNA copy number.
365
There seems to be a few nt. in the EV-A71 viral genome that are attenuating the virus as the 
Quantitation of viral titre by plaque assay
Discussion
390
In our previous investigation, we genetically engineered the EV-A71 sub-genotype B4
391
(5865/Sin/000009) through site directed mutagenesis via the substitution of nt. at positions 392 475, 486, and 487 as these nts. were the molecular determinants of neurovirulence in PV 
